GSK’s respiratory syncytial virus older adult vaccine candidate granted Priority Review by US FDA
This is the third major regulatory milestone for the vaccine candidate following acceptance of regulatory submissions in Europe and Japan
This is the third major regulatory milestone for the vaccine candidate following acceptance of regulatory submissions in Europe and Japan
Most of the new growth Capex investments are happening on the Specialty Chemicals and Nutrition side
His experience covers a wide range of areas including advisory services in the field of accounting, taxation, corporate and commercial laws, and regulatory matters
According to IQVIA sales data for the 12-month period ending September 2022, the Gilenya Capsules, 0.5 mg market achieved annual sales of approximately US $1.8 billion
The participants discussed the latest developments under ABDM that shall enable true interoperability in the health sector and how effective adoption of ABDM can pave the way towards Universal Health Coverage
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
Acetaminophen injection had annual sales of US $72 million in the United States according to IQVIA data
Subscribe To Our Newsletter & Stay Updated